News and Analysis On: (NASDAQ: CYTK), (NASDAQ: MU)
Cytokinetics, Incorporated (NASDAQ: CYTK) stock has a market capitalization of $266.02 million with a high beta of 1.73. The stock’s current trading is $1.79, up 22.60 percent from its previous close of $1.46. It opened the session at $1.63 and oscillated in the range of $1.59 and $1.79 during its last trading session. The trading volume of the stock stands at 7.084 million shares, significantly higher than the average trading volume of 1.427 million shares.
View full press release